Clinical Trial Update: CMX001 in Post-transplant Patients With BK Virus Viruria [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for CMX001 in post-transplant patients with BK virus viruria (Phase 1/Phase 2) has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bk Virus Infection
• Viruria

Drugs mentioned

• CMX001 (brincidofovir)

Snippet

Sponsor: Jazz Pharmaceuticals | Conditions: Viruria | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-07-16